Dozens of COVID-19 Drugs in Development. Whats' Next?

The world was waiting for any sign of hope in countering the COVID-19 pandemic when researchers released the first encouraging drips of data from a large clinical trial of the antiviral remdesivir last month. The drug, they said, reduced the time to recovery from COVID-19 by a few days — not enough to be branded a ‘cure', but hopefully enough to relieve some pressure on overwhelmed health-care systems.

Read Full Article »
Show comments Hide Comments

Related Articles